artenimol has been researched along with Granulocytic Leukemia, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, J; Wu, X; Xu, F; Zhang, G; Zhang, X; Zhou, J | 1 |
| Lee, J; Shen, P; Wu, X; Zhang, G; Zhang, X | 1 |
| Lee, J; Wu, XH; Zhou, HJ | 1 |
3 other study(ies) available for artenimol and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation.
Topics: Artemisinins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Down-Regulation; Fusion Proteins, bcr-abl; Growth Inhibitors; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; NF-kappa B; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2012 |
Dihydroartemisinin inhibits the Bcr/Abl oncogene at the mRNA level in chronic myeloid leukemia sensitive or resistant to imatinib.
Topics: Antimalarials; Apoptosis; Artemisinins; Benzamides; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Genes, abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Mitochondria; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA, Messenger | 2013 |
Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells.
Topics: Antimalarials; Apoptosis; Artemisinins; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Sesquiterpenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2006 |